Rahul Agarwal

Rahul Agarwal

Auto-generated profile, based on publicly available information

Rahul Agarwal

Department of Life Sciences, School of Natural Sciences, Shiv Nadar University, Dadri, Chithera, Gautam Budh Nagar, Uttar Pradesh 201314, India

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2016 in Scientific Reports
Verified
Journal Article
Open access
SHSantanu Hati
Santanu Hati
STSayantan Tripathy
Sayantan Tripathy
PDPratip Kumar Dutta
Pratip Kumar Dutta
RARahul Agarwal
Rahul Agarwal
RSRamprasad Srinivasan
Ramprasad Srinivasan
SSSubhabrata Sen
Subhabrata Sen
The spiro[pyrrolidine-3, 3´-oxindole] moiety is present as a core in number of alkaloids with substantial biological activities. Here in we report design and synthesis of a library of compounds bearing spiro[pyrrolidine-3, 3´-oxindole] motifs that demonstrated exceptional inhibitory activity against the proliferation of MCF-7 breast cancer cells. The synthesis involved a one pot Pictet Spengler-Oxidative ring contraction of tryptamine to the desired scaffolds and occurred in 1:1 THF and water with catalytic trifluoroacetic acid and stoichiometric N-bromosuccinimide as an oxidant. Phenotypic profiling indicated that these molecules induce apoptotic cell death in MCF-7 cells. Target deconvolution with most potent compound 5l from the library, using chemical proteomics indicated histone deacetylase 2 (HDAC2) and prohibitin 2 as the potential cellular binding partners. Molecular docking of 5l with HDAC2 provided insights pertinent to putative binding interactions.

1 September 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PMPapiya Majumdar
Papiya Majumdar
CBChandramohan Bathula
Chandramohan Bathula
SBSuparna M. Basu
Suparna M. Basu
SDSubhendu K. Das
Subhendu K. Das
RARahul Agarwal
Rahul Agarwal
Benu Brata DasBenu Brata Das
Benu Brata Das

25 April 2016 in Database: The Journal of Biological Databases and Curation
Verified
Journal Article
Open access
PDF file
RARahul Agarwal
Rahul Agarwal
BKBinayak Kumar
Binayak Kumar
MJMsk Jayadev
Msk Jayadev
DRDhwani Raghav
Dhwani Raghav
ASashutosh singh
ashutosh singh
Cancer of large intestine is commonly referred as colorectal cancer, which is also the third most frequently prevailing neoplasm across the globe. Though, much of work is being carried out to understand the mechanism of carcinogenesis and advancement of this disease but, fewer studies has been performed to collate the scattered information of alterations in tumorigenic cells like genes, mutations, expression changes, epigenetic alteration or post translation modification, genetic heterogeneity. Earlier findings were mostly focused on understanding etiology of colorectal carcinogenesis but less emphasis were given for the comprehensive review of the existing findings of individual studies which can provide better diagnostics based on the suggested markers in discrete studies. Colon Rectal Cancer Gene Database (CoReCG), contains 2056 colon-rectal cancer genes information involved in distinct colorectal cancer stages sourced from published literature with an effective knowledge based information retrieval system. Additionally, interactive web interface enriched with various browsing sections, augmented with advance search facility for querying the database is provided for user friendly browsing, online tools for sequence similarity searches and knowledge based schema ensures a researcher friendly information retrieval mechanism. Colorectal cancer gene database (CoReCG) is expected to be a single point source for identification of colorectal cancer-related genes, thereby helping with the improvement of classification, diagnosis and treatment of human cancers. Database URL: lms.snu.edu.in/corecg

1 July 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SHSantanu Hati
Santanu Hati
SMSanjay M. Madurkar
Sanjay M. Madurkar
CBChandramohan Bathula
Chandramohan Bathula
CTChiranjeevi Thulluri
Chiranjeevi Thulluri
RARahul Agarwal
Rahul Agarwal
SSSubhabrata Sen
Subhabrata Sen

17 September 2015 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
CBChandramohan Bathula
Chandramohan Bathula
PDPoonam Dangi
Poonam Dangi
SHSantanu Hati
Santanu Hati
RARahul Agarwal
Rahul Agarwal
PMParthapratim Munshi
Parthapratim Munshi
SSSubhabrata Sen
Subhabrata Sen
Several natural product inspired fused and spiro-heterocyclic scaffolds were prepared by ring distortion and ring construction strategies and evaluated for anti-breast cancer activity. A facile domino Pictet–Spengler lactamization (PSL) afforded nine natural product inspired indolo[2,3-a]quinolizidine and indolo[8,7-b]indolizidine scaffolds which are converted to seven other scaffolds by functional group transformation, ring distortion and ring construction strategies. In vitro screenings of this library of sixteen scaffolds with six distinct architectures against MCF7 cell lines afforded two compounds (10 and 21) with modest activity. Principal component analysis of this library against databases of FDA approved drugs, commercial compounds and FDA approved breast cancer compounds indicated an eclectic mix of structures among the molecules.

25 May 2016 in Scientific Reports
Verified
Journal Article
Open access
RMRajinikanth Mamidala
Rajinikanth Mamidala
PMPapiya Majumdar
Papiya Majumdar
KJKunal Kumar Jha
Kunal Kumar Jha
CBChandramohan Bathula
Chandramohan Bathula
RARahul Agarwal
Rahul Agarwal
SSSubhabrata Sen
Subhabrata Sen
A library of arylidenefuropyridinediones was discovered as potent inhibitors ofLeishmania donovaniTopoisomerase 1 (LdTop1) where the active molecules displayed considerable inhibition with single digit micromolar EC50values. This molecular library was designedviaintuitive scaffold hopping and bioisosteric modification of known topoisomerase 1 inhibitors such as camptothecin, edotecarin and etc. The design was rationalized by molecular docking analysis of the compound prototype with human topoisomerase 1 (HTop1) andLeishmania donovanitopoisomerase 1(LdTop1). The most active compound4displayed no cytotoxicity against normal mammalian COS7 cell line (~100 fold less inhibition at the EC50). Similar to camptothecin,4interacted with free LdTop1 as observed in the preincubation DNA relaxation inhibition experiment. It also displayed anti-protozoal activity againstLeishmania donovanipromastigote. Crystal structure investigation of4and its molecular modelling with LdTop1 revealed putative binding sites in the enzyme that could be harnessed to generate molecules with better potency.